Mechanistic insight into RNA-mediated toxicity of C9orf72-linked ALS/FTD
C9orf72 连接的 ALS/FTD 的 RNA 介导毒性的机制见解
基本信息
- 批准号:10019613
- 负责人:
- 金额:$ 19.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-18 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityAntisense OligonucleotidesAutopsyBiological ModelsBrainC9ORF72Cell LineCell modelClinicalDipeptidesDiseaseFluorescent in Situ HybridizationGenesGeneticGenetic EngineeringGenomicsGrantHuman EngineeringImmunofluorescence ImmunologicIn VitroLeadLengthLinkMS2 coat proteinMammalian CellMediatingMolecular StructureMotor NeuronsMusNerve DegenerationNeurodegenerative DisordersNeurodevelopmental DisorderNeuromuscular DiseasesNeuronsNuclear RNAPathogenesisPathogenicityPathologicPatientsPhenocopyPhenotypePhysiologicalPlayProductionProtein ArrayProteinsProteomicsRNARNA-Binding ProteinsRNA-Protein InteractionSamplingSpinocerebellar AtaxiasSpinocerebellar DegenerationsTestingTimeTissue MicroarrayTissuesToxic effectTranslationsUntranslated RNAValidationc9FTD/ALSdesigndisease phenotypefrontotemporal lobar dementia-amyotrophic lateral sclerosisgain of functioninduced pluripotent stem cellinsightloss of functionneuropathologynew therapeutic targetoverexpressionpreventprotein functionunpublished works
项目摘要
Expanded GGGGCC (G4C2) hexanucleotide repeats in the C9orf72 gene were recently identified as the
most common genetic cause of Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD), two
neurodegenerative disorders with genetic and pathological overlap. Repeat-RNA-toxicity mediated by
sequestering key RNA binding proteins is thought to play key roles in c9ALS/FTD pathogenesis. However,
which RNA binding protein(s) might be sequestered by long G4C2 repeat RNAs is still unknown. We propose to
identify RNA-protein interactions in c9ALS/FTD using disease-relevant repeat lengths and cell models, and by
comparison to interacting-proteins of (TG3C2) repeats, a similar repeat expansion that leads to a clinically
disparate disease Spinocerebellar Ataxia type 36 (SCA36). The identified RNA binding protein(s) by the G4C2
repeats will be further validated in c9ALS/FTD patient postmortem brain samples and its functions will be
studied in iPS-derived motor neurons and in mice. Results from this proposal will provide new insight into the
cellular cascades that cause neurodegeneration in c9ALS/FTD.
C9orf72 基因中扩展的 GGGGCC (G4C2) 六核苷酸重复最近被鉴定为
肌萎缩侧索硬化症(ALS)和额颞叶痴呆(FTD)最常见的遗传原因,两种
具有遗传和病理重叠的神经退行性疾病。重复RNA毒性介导
隔离关键 RNA 结合蛋白被认为在 c9ALS/FTD 发病机制中发挥关键作用。然而,
哪些 RNA 结合蛋白可能被长 G4C2 重复 RNA 隔离仍然未知。我们建议
使用疾病相关的重复长度和细胞模型来识别 c9ALS/FTD 中的 RNA-蛋白质相互作用,并通过
与 (TG3C2) 重复序列的相互作用蛋白相比,类似的重复序列扩展导致临床上
不同的疾病脊髓小脑性共济失调 36 型 (SCA36)。 G4C2 鉴定的 RNA 结合蛋白
重复序列将在 c9ALS/FTD 患者死后脑样本中得到进一步验证,其功能将被
在 iPS 衍生的运动神经元和小鼠中进行了研究。该提案的结果将为我们提供新的见解
导致 c9ALS/FTD 神经变性的细胞级联反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GARY J BASSELL其他文献
GARY J BASSELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GARY J BASSELL', 18)}}的其他基金
Single-Molecule Imaging of Ubiquitination Dynamics in Neurons
神经元泛素化动力学的单分子成像
- 批准号:
10817362 - 财政年份:2023
- 资助金额:
$ 19.13万 - 项目类别:
Mechanism and Function Of MBNL Mediated mRNA Localization in Neuronal Development and Neurologic Disease
MBNL介导的mRNA定位在神经元发育和神经系统疾病中的机制和功能
- 批准号:
10553695 - 财政年份:2020
- 资助金额:
$ 19.13万 - 项目类别:
Mechanism and Function Of MBNL Mediated mRNA Localization in Neuronal Development and Neurologic Disease
MBNL介导的mRNA定位在神经元发育和神经系统疾病中的机制和功能
- 批准号:
10334425 - 财政年份:2020
- 资助金额:
$ 19.13万 - 项目类别:
Dysregulated nascent proteome in human FX neuron
人类 FX 神经元新生蛋白质组失调
- 批准号:
10842046 - 财政年份:2020
- 资助金额:
$ 19.13万 - 项目类别:
RNA Processing-Mediated Mechanisms of CNS Dysfunction in Myotonic Dystrophy
强直性肌营养不良中 CNS 功能障碍的 RNA 加工介导机制
- 批准号:
10213864 - 财政年份:2019
- 资助金额:
$ 19.13万 - 项目类别:
RNA Processing-Mediated Mechanisms of CNS Dysfunction in Myotonic Dystrophy
强直性肌营养不良中 CNS 功能障碍的 RNA 加工介导机制
- 批准号:
10405913 - 财政年份:2019
- 资助金额:
$ 19.13万 - 项目类别:
RNA Processing-Mediated Mechanisms of CNS Dysfunction in Myotonic Dystrophy
强直性肌营养不良中 CNS 功能障碍的 RNA 加工介导机制
- 批准号:
10651422 - 财政年份:2019
- 资助金额:
$ 19.13万 - 项目类别:
相似海外基金
Development of Antisense Oligonucleotides to Regulate Gamma' Fibrinogen Levels
开发反义寡核苷酸来调节γ纤维蛋白原水平
- 批准号:
10759950 - 财政年份:2023
- 资助金额:
$ 19.13万 - 项目类别:
Inducing H3F3A exon skipping with antisense oligonucleotides as an approach to treat diffuse intrinsic pontine glioma
用反义寡核苷酸诱导 H3F3A 外显子跳跃作为治疗弥漫性内源性脑桥胶质瘤的方法
- 批准号:
10677284 - 财政年份:2023
- 资助金额:
$ 19.13万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10464020 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Promoting adult hippocampal neurogenesis using antisense oligonucleotides as an Alzheimer's disease therapy
使用反义寡核苷酸促进成人海马神经发生作为阿尔茨海默氏病的治疗
- 批准号:
10484703 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Strategy for specific delivery of antisense oligonucleotides to T cells
将反义寡核苷酸特异性递送至 T 细胞的策略
- 批准号:
10547347 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10806783 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10689248 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Metabolism of Antisense Oligonucleotides and other Polyanions in Liver
反义寡核苷酸和其他聚阴离子在肝脏中的代谢
- 批准号:
10501862 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Inducing PKM splice-switching with antisense oligonucleotides as an approach to treat hepatocellular carcinoma
用反义寡核苷酸诱导 PKM 剪接转换作为治疗肝细胞癌的方法
- 批准号:
10623180 - 财政年份:2022
- 资助金额:
$ 19.13万 - 项目类别:
Identifying binding partners, biological substrates and antisense oligonucleotides regulating expression of short and long ACE2.
识别调节短和长 ACE2 表达的结合伴侣、生物底物和反义寡核苷酸。
- 批准号:
BB/V019848/1 - 财政年份:2021
- 资助金额:
$ 19.13万 - 项目类别:
Research Grant